News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
New Research Highlight: Amivantamab With TKIs for Advanced NSCLC – ALK Positive Inc.
ALK Positive Inc./LinkedIn
Jan 14, 2025, 18:08

New Research Highlight: Amivantamab With TKIs for Advanced NSCLC – ALK Positive Inc.

ALK Positive Inc. shared a post on LinkedIn:

“New Research Highlight: Amivantamab With TKIs for Advanced NSCLC.

Exciting advancements in lung cancer treatment are on the horizon! Researchers are now exploring the combination of Amivantamab with Tyrosine Kinase Inhibitors (TKIs) for advanced NSCLC patients with ALK, ROS1, or RET alterations for those progressing on their current targeted therapy.

Why is this important?

This combination therapy has the potential to enhance treatment outcomes for patients with specific genetic drivers of lung cancer, offering new hope for improved survival and quality of life.

Dive into the details.”

More posts featuring ALK Positive Inc.

ALK Positive Inc Amivantamab cancer Lung cancer NSCLC OncoDaily Oncology TKIs Tyrosine kinase inhibitors
Special Coverage
Science
Jan 14, 2025, 19:05
Shaida Ouladan: Chimeric Antigen Receptor-T Cells in Colorectal Cancer
Societies
Jan 14, 2025, 19:03
Become a CancerX 2025 Accelerator Mentor
Blog
Jan 14, 2025, 18:58
Professor Tak Mak shares the story behind his discovery of the T Cell Receptor - SPCC
Science
Jan 14, 2025, 18:51
Abi Siva: Another step close to De-escalation
Science
Jan 14, 2025, 18:49
Naveen Pemmaraju: Addition of navitoclax to ruxolitinib for patients with myelofibrosis
Blog
Jan 14, 2025, 18:47
Zeena Salman: Five-year anniversary working with St. Jude Children's Research Hospital
Dialogues
Jan 14, 2025, 18:45
United by Unique: Centering Care Around People and Their Stories
Blog
Jan 14, 2025, 18:40
Anna Rathkopf: Learning about Breast Density after a cancer diagnosis
Blog
Jan 14, 2025, 18:40
GSK has announced agreement to acquire the U.S. biotech firm IDRx for up to $1.15 billion
Blog
Jan 14, 2025, 18:30
Keynote Lecture by Pamela Kunz to Highlight Need for Inclusive Science in GI Cancers - ASCO
Blog
Jan 14, 2025, 18:21
Applications are open for the LUNGevity Research Awards
Insight
Jan 14, 2025, 18:15
James Crowley: ctDNA Origins, Cancer Biology and Clinical Study Needs